occurred at the level of patient, general practitioner, general physician, or cardiologist. At angiography elderly patients had more severe and extensive coronary disease and had developed greater myocardial impairment, and as these factors, the severity of symptoms, and the need for urgent surgery have all been identified as predictors of surgical mortality6 these patients have an intrinsically higher operative risk, even before the effect of age is considered. We believe, therefore, that earlier referral and investigation of elderly patients who may be candidates for cardiac surgery-at a stage when their symptoms are limiting but not yet unstable-would yield a group for whom surgery could provide important symptomatic benefit, but at lower risk.
The implementation of such a policy would, in the context of our changing demography, place increased stress on already seriously overextended cardiac diagnostic facilities and staffing.7 Additionally, the provision of cardiac surgery within the NHS has tended to be restricted, and most cardiac surgery units have long waiting lists, often extending to over a year for nonurgent cases. In such circumstances of limited resources there is a danger that the medical needs of elderly patients may be looked on less favourably than those of younger patients, a prejudice termed agism. 8 Although this method of discriminating between patients competing for a finite resource may be convenient, it is rarely rational, and we are not aware of any public consensus regarding prejudicial selection on the grounds of age as a means of distributing treatment within the NHS. If finite resources require some patients to receive less than optimal treatment then this should be enacted by excluding those with less potential for benefit. A 70 year old patient with limiting angina and an average life expectancy of [10] [11] [12] [13] [14] years may often have such potential overlooked.
The successful outcome of coronary artery surgery in elderly patients with stable symptoms who are found at angiography to have coronary disease suitable for elective surgery supports the view that it is appropriate for an elderly patient with limiting angina to be referred for coronary angiography and, when necessary, added to the cardiac surgical waiting list. Only in this way can the necessary level of funding for cardiac surgery be identified. 5 Mock MB. Prognosis of coronary heart disease in the elderly patient: the CASS experience. In: Coodley EL, ed. Geriatric heart disease. Setting-Trials had been conducted in hospital clinics (6) , industry (3), mental hospitals or institutions (3), and in general populations (4) .
Patients-Trials had been conducted in high risk subjects (5), in unselected healthy subjects (6), or for secondary prevention in patients with coronary heart disease (5). Women were included in only four trials.
Interventions-Diets equivalent to the step 1 diet were employed in eight trials, with individual intervention by dietitians (3) or occupational physicians (2) or with population advice (3). Intensive diets which were more rigorous than the step 2 diet were employed in eight trials.
Main outcome measures-Net change in serum total cholesterol concentration in subjects receiving treatment with diet compared with values in control subjects after six months to 10 years.
Results-In five trials with the step 1 diet as individual intervention the net reduction in serum cholesterol concentration ranged from 0% to 4*0% over six months to six years. In trials with population education reductions in cholesterol concentrations were 0-6-2-0% over five to 10 years. When population and individual dietary advice were combined changes in cholesterol concentration ranged from a fall of 2-1% to a rise of 1-0% over four to 10 years. Diets more intensive than the step 2 diet reduced serum cholesterol concentration by 13% over five years in selected high risk men in the population; by 6-5-15*1% over two to five years in hospital outpatients; and by 12-8-15-5% over one to four and a halfyears in patients in institutions.
Conclusions-The response to a step 1 diet is too small to have any value in the clinical management of adults with serum cholesterol concentrations above 6-5 mmol/l. Current guidelines recommend screening of serum cholesterol concentration in healthy subjects, foliowed by treatment with a step 1 diet. The guidelines should be reviewed to provide a more realistic estimate of the effect of a step 1 diet and of the likely need for lipid lowering drugs.
Introduction
Every 1% reduction in serum cholesterol concentration reduces the risk of coronary events by about 1-2%.' Guidelines for managing patients with high cholesterol concentrations concur that diet is of prime importance in management,2-7 and advocate as initial treatment the step 1,6 or general lipid lowering diet (box). Diets recommended for reduction of serum cholesterol6
Step I diet * Total fat-less than 30% of total calories * Ratio of polyunsaturated fat to saturated fat-1.0 * Cholesterol-less than 300 mg daily * Calories-reduced to achieve desirable weight
Step 2 diet * Total fat-less than 30% of total calories * Ratio of polyunsaturated fat to saturated fat-1-4 * Cholesterol-less than 200mg daily * Calories-reduced to achieve desirable weight Organisation trial probably reflects maximum effort, whereas the 0 9% reduction at five to six years in the United Kingdom heart disease prevention project typifies responses at other times during the trial. In the multiple risk factor intervention trial dietary advice started with weekly small group sessions, followed by individual counselling by behavioural scientists and nutritionists. In the diet and reinfarction trial advice was given by hospital dietitians who visited and telephoned regularly to reinforce their instructions. In the trial of Curzio et al individualised dietary advice was provided by hospital dietitians. Subjects in these trials evidently had the benefit ofindividual instruction at least equal to that currently available in ordinary practice.
In the multiple risk factor intervention trial the diet conformed to the step 1 diet initially, but it was intensified later to give a polyunsaturated fat to saturated fat ratio of 1 25 and cholesterol intake of 250mg daily. The 2% reduction in cholesterol concentration at six years was therefore achieved by a diet more intensive than the step 1 diet. In the diet and reinfarction trial no mention was made of dietary cholesterol reduction, but this does not influence the response.32 The diet employed by Curzio et al was equivalent to a step 1 diet for most patients, but it was more rigorous in some [J Curzio, personal communication]. The diets used were therefore more intensive than the step 1 diet in two trials, and broadly equivalent to the step 1 diet in the others. Dietary adherence was assessed only in the diet and reinfarction trial and was incomplete. 27 Summary-These trials encompass different clinical settings, including ptimary prevention in high risk men22 24 26 or hypertensive patients28 and secondary prevention after myocardial infarction.27 Despite this, changes in serum cholesterol concentration differed little, with a mean fall of about 2% (range 0-4%). Small reductions in cholesterol concentration cannot be attributed to lack of statistical power, changes in control groups, or subject selection. The precise contribution of inadequate intervention effort, nonadherence, and an insufficiently rigorous diet is uncertain, but diets at least equivalent to the step 1 diet clearly have a meagre effect on cholesterol concentration given the resources available and adherence expected in ordinary practice.
Mass intervention with step I diet-In the controlled but not random north Karelia trial population education produced net reductions in serum cholesterol concentration of2-3% at five to 10 years. '33 Reductions in men (3-4%) were significant but those in women (1%) were not. In the Stanford five city project population intervention achieved non-significant mean reductions in cholesterol concentration of 0-6% by cohort sampling and 1-7% by cross sectional sampling after five years. 30 Combined individual and mass intervention-Three studies examined population education combined with individual advice to high risk subjects. In the United Kingdom heart disease prevention project serum cholesterol concentration increased by 1 0% at five to six years, and in the World Health Organisation European trial there was a reduction of 2 1% at four years. In the Gothenburg trial the net fall in serum cholesterol concentration at 10 years was 0 2%.3' This small response was attributed to a fall in cholesterol concentration in control subjects. At four years, however, intervention reduced cholesterol concentration by 1-2% from control values, and 0-6% from baseline values. Changes in control subjects clearly could not explain the small response at four years.
TRIALS OF MORE RIGOROUS DIET
The Oslo study' 35 deserves special attention because it is invariably cited to support the dietary measures recommended in various guidelines. In this random controlled trial diet reduced serum cholesterol concentration by 13% over five years (table II) , and, in conjunction with a reduction in cigarette smoking, reduced the incidence of myocardial infarction and sudden death by 47%. Several important points are commonly overlooked. Men were recruited by a single letter of invitation, and the 35% who did not respond probably included those least likely to comply. Subjects were then selected according to their dietary habits." Those already following a fat restricted diet were excluded, but the number excluded was not stated. The men studied had severely increased serum cholesterol concentration of between 7 5 mmol/ and 9 8mmol/1. Perhaps because of these selection procedures the subjects had a very high intake of dietary fat, averaging 44% of total energy. This is much higher than the average intake in British men (35.37%27 3) or the United States population (35 40%6) . The diet used reduced total fat intake to 28% of energy intake and raised the ratio of polyunsaturated fat to saturated fat from 0 39 to 1 01, and it was more rigorous than the step 2 diet (for which total fat intake can be up to 30%.) BMJ VOLUME 303
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The correct conclusion from the Oslo study is that rigorous dietary intervention in male volunteers with very high serum cholesterol concentrations and very high dietary fat intake caused a substantial fall in serum cholesterol concentration. Together with some reduction in cigarette smoking this resulted in an important decline in the incidence of coronary heart disease. Its results cannot, however, be extrapolated generally, particularly to those with less severe hyperlipidaemia; to those with more typical dietary fat intake; to women; or to the outcome with the step 1 diet. The Oslo study does not, in short, support the policies set out in recent guidelines and, conversely, recent guidelines do not recommend the form of intervention tested so successfully in the study.
In four small trials in free living subjects rigorous low fat diets reduced serum cholesterol concentration substantially by 6-5-15-1% (table II) .82037 In three controlled trials in people living in institutions serum cholesterol concentration was reduced by 12-8-15-5% over one year to four and a half years (table II) . The diets studied were very intensive, attaining ratios of polyunsaturated fats to saturated fats of 1-638 and I-5U," whereas the step 2 diet aims at a ratio ofonly 1-4. These trials leave no doubt that modification of diet can lower serum cholesterol concentration substantially, but the diets were all more intense than those now advised and, in varying degrees, unpalatable. It seems that the dietary treatment must be unpleasant to be effective.
Discussion
Dietary change undoubtedly can lower serum cholesterol concentration, as shown by reductions averaging 12% over one to five years with rigorous diets. 18-21 34 35 37-39 However, the step 1 diet has little effect on serum cholesterol concentration in free living subjects. In trials of intervention in individual high risk subjects reductions in cholesterol concentration have averaged about 2% (range 0-4%) over six months to six years. These small responses could be due to inadequate intervention effort in some studies,24 27 but not others,26 or to incomplete adherence,2737 but above all reflect an insufficiently rigorous diet. Responses were similarly small in trials of population education293033 and when population education was combined with individual advice for subjects at higher risk,2225 31 6% given the adherence expected in ordinary practice. " In the event this projection has proved overoptimistic. The best estimate of cholesterol reduction is 2%, and even the smallest trials had sufficient power to exclude reductions as large as 6%. These small responses occurred despite resources at least equal to those currently available in ordinary practice. What benefit might be expected from the reductions in serum cholesterol concentration observed in these trials of the step 1 diet? By using as a rule of thumb a -5% reduction in coronary events for a 1% fall in total cholesterol concentration,' a fall of 2% may translate to a reduction in coronary events of about 3%. A more rigorous diet is required to attain any important reduction in serum cholesterol concentration, but the feasibility, acceptability, and effectivenss of the step 2 diet have not been tested in long term controlled trials in free living subjects. The trials summarised in table II all employed diets more rigorous than the step 2 diet.
These results contrast sharply with assertions in many guidelines and reviews that serum cholesterol concentration will fall by 10-25% in response to a step 1 diet.4"8'44' Why are perceptions of efficacy so unrealistic? Among the reasons are overreliance on short term experiments, controlled studies of rigorous diets in "captive" populations, and uncontrolled observations. The Oslo study has understandably been given considerable weight, but with no recognition that the subjects were highly selected and the diet much more rigorous than the step 1 diet. Evidence from the other controlled trials reviewed here has been ignored, with uncontrolled studies purporting to show efficacy being cited instead. For 
